Insider Transactions in Q1 2025 at Spero Therapeutics, Inc. (SPRO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 05
2025
|
Timothy Keutzer Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
56,537
-2.41%
|
$0
$0.78 P/Share
|
|
Feb 05
2025
|
Esther Rajavelu CFO & CBO |
SELL
Open market or private sale
|
Direct |
20,689
-2.78%
|
$0
$0.78 P/Share
|
|
Feb 05
2025
|
Ankit Mahadevia |
SELL
Open market or private sale
|
Direct |
69,219
-4.63%
|
$0
$0.78 P/Share
|
|
Feb 05
2025
|
Sath Shukla CEO & President |
SELL
Open market or private sale
|
Direct |
155,333
-2.79%
|
$0
$0.78 P/Share
|
|
Feb 03
2025
|
Timothy Keutzer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
266,139
+25.01%
|
-
|
|
Feb 03
2025
|
Esther Rajavelu CFO & CBO |
BUY
Grant, award, or other acquisition
|
Direct |
366,139
+20.51%
|
-
|
|
Feb 03
2025
|
Sath Shukla CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
751,407
+28.42%
|
-
|